Register for our free email digests:
Andromeda Biotech Ltd.
Division of Horizon Therapeutics PLC
www.andromedabio.com
Latest From Andromeda Biotech Ltd.
Evotec Expands Sanofi Link With Exclusive Stem Cell Diabetes Deal
Evotec’s deal with the French drugmaker to develop stem cell-based treatments for diabetes takes on even more importance following the demise of the biotech’s two lead proprietary candidate therapies.
Deal Watch: Teva Boosts CNS Portfolio With $3.2 Billion Purchase Of Auspex
Novartis raises its game in immuno-oncology through Aduro collaboration, while Merck Serono partners up with a CAR-T program at Intrexon. UnitedHealth grows its PBM business by acquiring Catamaran; Horizon expands its orphan drug portfolio in buyout of Hyperion.
Evotec CEO: Growth Prospects Rely Heavily On Roche, Sanofi Deals
After disappearance last year of its drug hope DiaPep277 due to fraud, Germany’s Evotec is now looking to its Alzheimer’s MAO partnership with Roche and newly entered R&D alliance with Sanofi for future growth.
Andromeda settlement gives Hyperion little unless drug succeeds
Hyperion Therapeutics settled with former Andromeda Biotech parent company Clal Biotechnology Industries (CBI) in relation to Hyperion's desired disposition of Andromeda, a business it bought from CBI in 2014 without knowledge of data tampering related to lead product candidate DiaPep277.
Company Information
- Industry
-
Biotechnology
- Large Molecule
- Pharmaceuticals
- Therapeutic Areas
- Metabolic Disorders
- Alias(es)
- Ownership
- Private
- Headquarters
-
Worldwide
-
Middle East
-
Israel
-
Israel
-
Middle East
- Parent & Subsidiaries
- Horizon Therapeutics PLC
- Senior Management
-
Shlomo Dagan, PhD, CEO
Chaim Eldar, CFO
Rachel Eren, VP, Clinical Dev. - Contact Info
-
Andromeda Biotech Ltd.
Phone: (972)
42 Hayarkon St.
Yavne, 81227
Israel
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice